305 related articles for article (PubMed ID: 27785591)
21. Enhancement of in vitro and in vivo tumor cell radiosensitivity by the DNA methylation inhibitor zebularine.
Dote H; Cerna D; Burgan WE; Carter DJ; Cerra MA; Hollingshead MG; Camphausen K; Tofilon PJ
Clin Cancer Res; 2005 Jun; 11(12):4571-9. PubMed ID: 15958643
[TBL] [Abstract][Full Text] [Related]
22. Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma.
Brun SN; Markant SL; Esparza LA; Garcia G; Terry D; Huang JM; Pavlyukov MS; Li XN; Grant GA; Crawford JR; Levy ML; Conway EM; Smith LH; Nakano I; Berezov A; Greene MI; Wang Q; Wechsler-Reya RJ
Oncogene; 2015 Jul; 34(29):3770-9. PubMed ID: 25241898
[TBL] [Abstract][Full Text] [Related]
23. Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cancer.
Balch C; Yan P; Craft T; Young S; Skalnik DG; Huang TH; Nephew KP
Mol Cancer Ther; 2005 Oct; 4(10):1505-14. PubMed ID: 16227399
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastoma.
Lindsey JC; Lusher ME; Anderton JA; Gilbertson RJ; Ellison DW; Clifford SC
Br J Cancer; 2007 Jul; 97(2):267-74. PubMed ID: 17579622
[TBL] [Abstract][Full Text] [Related]
25. miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma.
Weeraratne SD; Amani V; Neiss A; Teider N; Scott DK; Pomeroy SL; Cho YJ
Neuro Oncol; 2011 Feb; 13(2):165-75. PubMed ID: 21177782
[TBL] [Abstract][Full Text] [Related]
26. Valproic acid treatment response in vitro is determined by TP53 status in medulloblastoma.
Mascaro-Cordeiro B; Oliveira ID; Tesser-Gamba F; Pavon LF; Saba-Silva N; Cavalheiro S; Dastoli P; Toledo SRC
Childs Nerv Syst; 2018 Aug; 34(8):1497-1509. PubMed ID: 29785653
[TBL] [Abstract][Full Text] [Related]
27. Targeting inhibitors of apoptosis proteins suppresses medulloblastoma cell proliferation via G2/M phase arrest and attenuated neddylation of p21.
Chen SM; Lin TK; Tseng YY; Tu CH; Lui TN; Huang SF; Hsieh LL; Li YY
Cancer Med; 2018 Aug; 7(8):3988-4003. PubMed ID: 29984917
[TBL] [Abstract][Full Text] [Related]
28. Medulloblastoma: Molecular understanding, treatment evolution, and new developments.
Liu X; Ding C; Tan W; Zhang A
Pharmacol Ther; 2020 Jun; 210():107516. PubMed ID: 32105673
[TBL] [Abstract][Full Text] [Related]
29. An autocrine ActivinB mechanism drives TGFβ/Activin signaling in Group 3 medulloblastoma.
Morabito M; Larcher M; Cavalli FM; Foray C; Forget A; Mirabal-Ortega L; Andrianteranagna M; Druillennec S; Garancher A; Masliah-Planchon J; Leboucher S; Debalkew A; Raso A; Delattre O; Puget S; Doz F; Taylor MD; Ayrault O; Bourdeaut F; Eychène A; Pouponnot C
EMBO Mol Med; 2019 Aug; 11(8):e9830. PubMed ID: 31328883
[TBL] [Abstract][Full Text] [Related]
30. GLI2 is a potential therapeutic target in pediatric medulloblastoma.
Buczkowicz P; Ma J; Hawkins C
J Neuropathol Exp Neurol; 2011 Jun; 70(6):430-7. PubMed ID: 21572341
[TBL] [Abstract][Full Text] [Related]
31. Zebularine enhances apoptosis of human osteosarcoma cells by suppressing methylation of ARHI.
Ye K; Wang S; Wang J; Han H; Ma B; Yang Y
Cancer Sci; 2016 Dec; 107(12):1851-1857. PubMed ID: 27685841
[TBL] [Abstract][Full Text] [Related]
32. RBM5 Acts as Tumor Suppressor in Medulloblastoma through Regulating Wnt/β-Catenin Signaling.
Yu J; Ji G; Shi W; Zhao R; Shen W; Zheng J; Li H; Jiang F
Eur Neurol; 2020; 83(3):242-250. PubMed ID: 32610314
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Long Noncoding RNA CRNDE Increases Chemosensitivity of Medulloblastoma Cells by Targeting miR-29c-3p.
Sun XH; Fan WJ; An ZJ; Sun Y
Oncol Res; 2020 Feb; 28(1):95-102. PubMed ID: 31753063
[TBL] [Abstract][Full Text] [Related]
34. Neurotrophin receptors and heparanase: a functional axis in human medulloblastoma invasion.
Marchetti D; Mrak RE; Paulsen DD; Sinnappah-Kang ND
J Exp Clin Cancer Res; 2007 Mar; 26(1):5-23. PubMed ID: 17550129
[TBL] [Abstract][Full Text] [Related]
35. Detection of lower levels of SNAP25 using multiple microarray systems and its functional significance in medulloblastoma.
Huang CJ; Lee CL; Liu CY; Huang SH; Hou JW; Chen YH; Chien CC; Ho CM; Lo WC; Hung KL
Int J Mol Med; 2017 May; 39(5):1195-1205. PubMed ID: 28339008
[TBL] [Abstract][Full Text] [Related]
36. DNA methyltransferase inhibitor, zebularine, delays tumor growth and induces apoptosis in a genetically engineered mouse model of breast cancer.
Chen M; Shabashvili D; Nawab A; Yang SX; Dyer LM; Brown KD; Hollingshead M; Hunter KW; Kaye FJ; Hochwald SN; Marquez VE; Steeg P; Zajac-Kaye M
Mol Cancer Ther; 2012 Feb; 11(2):370-82. PubMed ID: 22203734
[TBL] [Abstract][Full Text] [Related]
37. BATF2 inhibits chemotherapy resistance by suppressing AP-1 in vincristine-resistant gastric cancer cells.
Yang W; Zhao S; Wu B; Xu J; Wu Z; Guo J; Zeng R
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1279-1288. PubMed ID: 31549215
[TBL] [Abstract][Full Text] [Related]
38. Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma.
Park AK; Lee JY; Cheong H; Ramaswamy V; Park SH; Kool M; Phi JH; Choi SA; Cavalli F; Taylor MD; Kim SK
BMC Cancer; 2019 Jun; 19(1):571. PubMed ID: 31185958
[TBL] [Abstract][Full Text] [Related]
39. Suppression of STAT3 NH
Ray S; Coulter DW; Gray SD; Sughroue JA; Roychoudhury S; McIntyre EM; Chaturvedi NK; Bhakat KK; Joshi SS; McGuire TR; Sharp JG
Mol Carcinog; 2018 Apr; 57(4):536-548. PubMed ID: 29280516
[TBL] [Abstract][Full Text] [Related]
40. c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients.
von Bueren AO; Oehler C; Shalaby T; von Hoff K; Pruschy M; Seifert B; Gerber NU; Warmuth-Metz M; Stearns D; Eberhart CG; Kortmann RD; Rutkowski S; Grotzer MA
BMC Cancer; 2011 Feb; 11():74. PubMed ID: 21324178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
